The CRED Biodiagnostic project have established a solid reputation in evaluation of diagnostics technologies, in Research, and in development and application of technologies and methodologies.
The activities of Biodiagnostic group are interested in development of innovative procedures in order to optimise the use and the cost of the diagnostic tests and equipment for use in patient diagnosis and patient management.
Systems and devices evaluation for Clinical purposes;
Multisites clinical evaluations;
Research and development of new markers for use in patient diagnosis and patient management;
Study on the impact of diagnostic tests on care efficiency;
Study on cost-effectiveness and pharmacoeconomy;
Implication in education and training.
Reaserch and development of the potential use of platelet activation as early marker of diagnosis/detection of coronary coronary syndrome, for monitoring of antiplatelet therapy and for evaluation of the cost-effectiveness of using this diagnostic test to support the judicious choice of antiplatelet therapy.
Clinical and Evaluation Studies
Sampling and Storage
Collaborative Research for Effective Diagnostics (CRED)
3201, rue Jean Mignault
Suite Z8-1030 for the mail
Door Z8-8 for the parcels
Sherbrooke QC Canada, J1E 4K8
Phone: (819) 821-8000 x 75894
Fax: (819) 820-6853